Position in TMO
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,552,636
+$3,157,262 QoQ
Shares Held
7,086
+832.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#954
of 2,606 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Fulcrum Capital LLC holds $3,552,636 across 1 Diagnostics & Research name. TMO ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
This page
|
7,086 | $3,552,636 |
All Filings in TMO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,552,636 | 7,086 | Shares | Sole | 2026-07-21 | |
| 2024-12-31 | $395,374 | 760 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $470,113 | 760 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $420,280 | 760 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $441,719 | 760 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $403,400 | 760 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $384,689 | 760 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $462,270 | 886 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $510,663 | 886 | Shares | Sole | 2023-05-11 | |
| No filing history on record for this holder in this stock. | ||||||